Medicare Enrolled
Dr. Michael Geffin, MD
Urology Physician · Plymouth, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Geffin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Geffin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Geffin
Dr. Michael Geffin is an urology physician in Plymouth, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Geffin performed 11,190 Medicare services across 4,547 unique beneficiaries.
Between the years covered by Open Payments, Dr. Geffin received a total of $12,572 from 56 pharmaceutical and/or device companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Geffin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in MA
$12,572 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,190
Medicare services
Top 4% in MA for urology physician
4,547
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~589 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 4,022 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,223 | $95 | $350 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
963 | $8 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
827 | $67 | $245 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
477 | $8 | $25 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
439 | $2 | $20 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
389 | $6 | $273 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
383 | $49 | $259 |
| PSA test (prostate cancer screening) | 348 | $18 | $100 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
219 | $186 | $725 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
147 | $25 | $89 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
141 | $117 | $477 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 127 | $134 | $750 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
117 | $72 | $289 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
95 | $49 | $85 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
90 | $20 | $50 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
83 | $72 | $450 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
81 | $18 | $100 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
79 | $8 | $25 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
78 | $49 | $300 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
77 | $38 | $239 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
67 | $102 | $375 |
| Injection, garamycin, gentamicin, up to 80 mg | 65 | $2 | $15 |
| Simple change of bladder tube | 59 | $77 | $300 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $40 | $150 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
47 | $8 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
43 | $11 | $90 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $64 | $275 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
38 | $54 | $289 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
37 | $174 | $800 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
28 | $31 | $361 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
28 | $93 | $350 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
27 | $326 | $1,981 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
26 | $135 | $3,500 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
26 | $40 | $150 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
24 | $124 | $2,292 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
22 | $538 | $3,500 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
20 | $37 | $85 |
| Complicated insertion of bladder tube | 18 | $124 | $500 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $132 | $389 |
| Ureteral stent removal with radiological review Removal of a stent from the ureter using a ureteroscope, with review by a radiologist. |
17 | $612 | $2,276 |
| Insertion of temporary bladder tube | 17 | $37 | $200 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
17 | $55 | $2,000 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
17 | $29 | $166 |
| Prostate needle biopsy with image guidance A procedure to remove small tissue samples from the prostate gland using a needle. Image guidance is used to help the doctor accurately locate the area for sampling. |
15 | $290 | $1,100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $72 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
14.9% medium
84.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,572
Total received (2018-2024)
Avg $1,796/year across 7 years
Top 15% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
254
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,239 (49.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,821 (46.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$513 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,262
2023
$834
2022
$727
2021
$556
2020
$357
2019
$1,810
2018
$7,028
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
DENTSPLY IH AB
$236
Sumitomo Pharma America, Inc.
$234
Janssen Biotech, Inc.
$186
AngioDynamics, Inc.
$123
ACCORD HEALTHCARE, INC.
$80
Novartis Pharmaceuticals Corporation
$60
Telix Pharmaceuticals
$39
Janssen Scientific Affairs, LLC
$34
Dendreon Pharmaceuticals LLC
$30
Antares Pharma, Inc.
$28
180 Medical, Inc.
$27
Endo USA, Inc.
$24
Endo Pharmaceuticals Inc.
$24
ABBVIE INC.
$24
PROGENICS PHARMACEUTICALS, INC.
$23
Bayer Healthcare Pharmaceuticals Inc.
$20
Myriad Genetic Laboratories, Inc.
$18
Astellas Pharma US Inc
$18
C. R. Bard, Inc. & Subsidiaries
$18
Calyxo, Inc.
$16
Top 3 companies account for 52.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$6,709
NeoTract Inc.
$1,063
Astellas Pharma US Inc
$669
Endo Pharmaceuticals Inc.
$392
DENTSPLY IH AB
$328
Progenics Pharmaceuticals, Inc.
$252
PFIZER INC.
$249
Sumitomo Pharma America, Inc.
$234
Dendreon Pharmaceuticals LLC
$228
TOLMAR Pharmaceuticals, Inc.
$167
Teleflex LLC
$159
Myriad Genetic Laboratories, Inc.
$154
180 Medical, Inc.
$151
Augmenix, Inc.
$139
AngioDynamics, Inc.
$123
Antares Pharma, Inc.
$108
Boston Scientific Corporation
$87
Novartis Pharmaceuticals Corporation
$84
ACCORD HEALTHCARE, INC.
$80
C. R. Bard, Inc. & Subsidiaries
$79
Rochester Medical Corporation
$70
Blue Earth Diagnostics Limited
$68
Amgen Inc.
$66
UroGen Pharma, Inc.
$63
Janssen Products, LP
$60
Medtronic USA, Inc.
$49
ConvaTec Inc.
$45
Palette Life Sciences, Inc.
$43
Telix Pharmaceuticals
$39
GENZYME CORPORATION
$35
UROVANT SCIENCES INC
$34
Janssen Scientific Affairs, LLC
$34
Egalet US Inc
$30
Acerus Pharmaceuticals Corporation
$30
Tolmar, Inc.
$28
BOSTON SCIENTIFIC CORPORATION
$28
Olympus America Inc.
$27
Encision Inc
$26
Axonics, Inc.
$25
Endo USA, Inc.
$24
ABBVIE INC.
$24
AbbVie Inc.
$24
PROGENICS PHARMACEUTICALS, INC.
$23
Avadel Specialty Pharmaceuticals, LLC
$23
AbbVie, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Sun Pharmaceutical Industries Inc.
$20
Laborie Medical Technologies Corp.
$18
Retrophin, Inc.
$18
ROCHESTER MEDICAL CORPORATION
$17
UROGEN PHARMA, INC.
$17
Calyxo, Inc.
$16
C. R. BARD, INC. & SUBSIDIARIES
$15
Travere Therapeutics, Inc.
$14
Ferring Pharmaceuticals Inc.
$13
TherapeuticsMD, Inc.
$11
Top 3 companies account for 67.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AVEED · Advantage System · Axonics · Axumin · BOTOX · BRACAnalysis · BRACAnalysis CDx · Bard Urinary Drainage Bag · CAMCEVI · CURE CATHETER · CVAC ASPIRATION SYSTEM · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL THERAPIES · GENERAL - BPH · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · ILLUCCIX · IMVEXXY · INLAY OPTIMA · INTERSTIM · JELMYTO · JEVTANA · LOFRIC · LUPRON DEPOT · LoFric · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Nubeqa · Otrexup · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolia · REZUM · SOLYX · SPEEDICATH · SPRIX · SpaceOAR · SpeediCath · TOVIAZ · UROLIFT · UroLift · UroLift System · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA (abiraterone acetate) · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (50%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
16
Per 100K population
3.0
County median income
$109,698
Nearest hospital
BETH ISRAEL DEACONESS HOSPITAL PLYMOUTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Geffin is a clinical cardiology specialist, with above-average Medicare volume (top 4% in MA), with mixed engagement industry engagement in the top 15% of MA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Geffin experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Geffin performed 4,022 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Geffin receive payments from pharmaceutical companies?
Yes. Dr. Geffin received a total of $12,572 from 56 companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Geffin's costs compare to other urology physicians in Plymouth?
Dr. Geffin's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Geffin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Plymouth
Browse urology physicians in Plymouth ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology